BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 893790)

  • 1. Technetium-99m stannous citrate brain-tumor uptake in mice: concise communication.
    Haynie TP; Konikowski T; Glenn HJ
    J Nucl Med; 1977 Sep; 18(9):915-8. PubMed ID: 893790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal clearance and brain tumor localization in mice of 99 m Tc compounds of (Sn), DTPA, (iron-ascorbic acid) DTPA, and iron-ascorbic acid.
    Konikowski T; Glenn HJ; Haynie TP
    J Nucl Med; 1972 Nov; 13(11):834-42. PubMed ID: 5080017
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain tumor-scanning agents compared in an animal model.
    Konikowski T; JPAHNS MF; Haynie P; Glenn HJ
    J Nucl Med; 1975 Mar; 16(3):200-7. PubMed ID: 46273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m labeled agents for skeletal imaging.
    Thrall JH
    CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortcomings of 99m Tc-pertechnetate as a tracer for brain tumor detection as shown by well counting of human brain tumors and a mouse ependymoblastoma.
    Schwartz ML; Tator CH
    J Nucl Med; 1972 May; 13(5):321-7. PubMed ID: 4336247
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics of 111In-bleomycin and 111 In-chlorides in mice.
    Konikowski T; Haynie TP; Glenn HJ
    J Nucl Med; 1975 Aug; 16(8):738-43. PubMed ID: 51922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor imaging after administration of 99mTc-labeled bleomycin.
    Mori T; Hamamoto K; Onoyama Y; Torizuka K
    J Nucl Med; 1975 May; 16(5):414-22. PubMed ID: 53278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
    van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the Tc 99m-Sn complex in brain scanning].
    Kuba J; Charamza OC; Klaus E; Sevcik M
    Radiobiol Radiother (Berl); 1971; 12(4):501-6. PubMed ID: 5140055
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-glucoheptonate as a brain-scanning agent: critical comparison with pertechnetate.
    Waxman AD; Tanacescu D; Siemsen JK; Wolfstein RS
    J Nucl Med; 1976 May; 17(5):345-8. PubMed ID: 1262934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the Tc 99m -Sn-complex in brain scintigraphy].
    Kuba J; Charamza O; Klaus E; Sevcík M
    Radiol Diagn (Berl); 1971; 12(4):501-6. PubMed ID: 5147685
    [No Abstract]   [Full Text] [Related]  

  • 14. Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.
    Subramanian G; McAfee JG; Blair RJ; Rosenstreich M; Coco M; Duxbury CE
    J Nucl Med; 1975 Dec; 16(12):1137-43. PubMed ID: 1194964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ distribution of 99m-Tc-and 51-Cr-labelled thymocytes.
    Barth RF; Singla O
    J Nucl Med; 1975 Jul; 16(7):633-8. PubMed ID: 1151482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide scanning in the evaluation of Kaposi sarcoma.
    Krishnamurthy GT; Singhi V; Taylor RD; Ranganath K; Blahd WH
    Arch Intern Med; 1976 Apr; 136(4):400-3. PubMed ID: 944558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
    Fritzberg AR; Lyster DM; Dolphin DH
    J Nucl Med; 1977 Jun; 18(6):553-7. PubMed ID: 192859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetics of 99m Tc-, 113m In-, and 169 Yb-DTPA compounds in brain sarcoma and kidneys of mice.
    Haynie TP; Konikowski T; Glenn HJ
    J Nucl Med; 1972 Mar; 13(3):205-10. PubMed ID: 5058238
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of perchlorate on the localization of 99mTc-pertechnetate in a mouse brain sarcoma.
    Konikowski T; Haynie TP
    J Nucl Med; 1970 Jul; 11(7):443-8. PubMed ID: 4317181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.